Riikka Räty

3.1k total citations
46 papers, 1.3k citations indexed

About

Riikka Räty is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Riikka Räty has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 13 papers in Genetics. Recurrent topics in Riikka Räty's work include Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Viral-associated cancers and disorders (9 papers). Riikka Räty is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Viral-associated cancers and disorders (9 papers). Riikka Räty collaborates with scholars based in Finland, Denmark and Norway. Riikka Räty's co-authors include Erkki Elonen, Mats Jerkeman, Arne Kolstad, Kirsten Grønbæk, Christian H. Geisler, Lone Bredo Pedersen, Anna Laurell, Christian Winther Eskelund, Sara Ek and Kaarle Franssila and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Riikka Räty

46 papers receiving 1.3k citations

Peers

Countries citing papers authored by Riikka Räty

Since Specialization

Citations

This map shows the geographic impact of Riikka Räty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riikka Räty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riikka Räty more than expected).

Fields of papers citing papers by Riikka Räty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riikka Räty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riikka Räty. The network helps show where Riikka Räty may publish in the future.

Co-authorship network of co-authors of Riikka Räty

This figure shows the co-authorship network connecting the top 25 collaborators of Riikka Räty. A scholar is included among the top collaborators of Riikka Räty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riikka Räty. Riikka Räty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 – a Nordic Lymphoma Group study 2023 ·Haematologica ·(unknown), Peter Hollander, (unknown), (unknown), (unknown), Darshan Kumar, Christian H. Geisler, Kirsten Grønbæk, Christian Winther Eskelund, Riikka Räty, Arne Kolstad, Christer Sundström, Ingrid Glimelius, Anna Porwit, Mats Jerkeman, Sara Ek	5
2	Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas 2023 ·Haematologica ·Suvi‐Katri Leivonen, (unknown), Matias Autio, Samuli Vaittinen, (unknown), Francesco d’Amore, Stephen Hamilton‐Dutoit, Harald Holte, Klaus Beiske, Panu E. Kovanen, Riikka Räty, Sirpa Leppä	2
3	Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL 2022 ·Leukemia ·Simon Husby, (unknown), Christian Winther Eskelund, Francesco Favero, Jakob S. Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten Utoft Niemann, Joachim Weischenfeldt, Riikka Räty, Thomas Stauffer Larsen, Arne Kolstad, Mats Jerkeman, Kirsten Grønbæk	3
4	Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors 2022 ·Haematologica ·Anna Sandström Gerdtsson, (unknown), Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Riikka Räty, Arne Kolstad, Christian H. Geisler, Anna Porwit, Mats Jerkeman, Sara Ek	2
5	Infiltration of CD163‐, PD‐L1‐ and FoxP3‐positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors 2021 ·British Journal of Haematology ·(unknown), (unknown), Peter Hollander, Caroline E. Weibull, Riikka Räty, Arne Kolstad, Rose‐Marie Amini, Anna Porwit, Mats Jerkeman, Sara Ek, Ingrid Glimelius	17
6	Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials 2021 ·Leukemia ·Mette Dahl, Simon Husby, Christian Winther Eskelund, Søren Besenbacher, (unknown), Christophé Côme, Sara Ek, Arne Kolstad, Riikka Räty, Mats Jerkeman, Christian H. Geisler, Jørgen Kjems, Lasse S. Kristensen, Kirsten Grønbæk	21
7	p53 is associated with high‐risk and pinpointsTP53missense mutations in mantle cell lymphoma 2020 ·British Journal of Haematology ·(unknown), (unknown), C. Freiburghaus, Christian Winther Eskelund, Christian H. Geisler, Riikka Räty, Arne Kolstad, Christer Sundström, Ingrid Glimelius, Kirsten Grønbæk, (unknown), Anna Porwit, Mats Jerkeman, Sara Ek	33
8	TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy 2017 ·Blood ·Christian Winther Eskelund, Christina Dahl, Jakob Werner Hansen, Maj Westman, Arne Kolstad, Lone Bredo Pedersen, Carmen P. Montano‐Almendras, Simon Husby, C. Freiburghaus, Sara Ek, Anja Pedersen, Carsten Utoft Niemann, Riikka Räty, Peter de Nully Brown, Christian H. Geisler, Mette Klarskov Andersen, Per Guldberg, Mats Jerkeman, Kirsten Grønbæk	242
9	Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma 2016 ·Blood ·(unknown), Arne Kolstad, Anna Laurell, Riikka Räty, Kirsten Grønbæk, J. Sundberg, Lone Bredo Pedersen, Elisabeth Ralfkiær, Marja-Liisa Karjalainen-Lindsberg, Christer Sundström, Mats Ehinger, Christian H. Geisler, Mats Jerkeman	62
10	MicroRNA Profiling in Chemoresistant and Chemosensitive Acute Myeloid Leukemia 2013 ·Cytogenetic and Genome Research ·Neda Mosakhani, Riikka Räty, (unknown), Marja‐Liisa Karjalainen‐Lindsberg, Erkki Elonen, Sakari Knuutila	22
11	Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations 2013 ·Genomics ·Virinder Kaur Sarhadi, Leo Lahti, Ilari Scheinin, (unknown), Suvi Savola, (unknown), Riikka Räty, Erkki Elonen, Pekka Ellonen, Ulla M. Saarinen‐Pihkala, Sakari Knuutila	13
12	Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Hannu Syrjälä, Pasi Ohtonen, (unknown), Riikka Räty, Erkki Elonen, T. Nousiainen, Esa Jantunen, Kari Remes, Maija Itälä‐Remes, Raija Silvennoinen, P. Koistinen	28
13	Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data 2010 ·Leukemia Research ·(unknown), Erkki Elonen, Ulla M. Saarinen‐Pihkala, Riikka Räty, Arja Harila‐Saari, Pirjo Koistinen, Eeva‐Riitta Savolainen, Sakari Knuutila, Jaakko Hollmén	13
14	Mantle cell lymphoma – does primary intensive immunochemotherapy improve overall survival for younger patients? 2009 ·Leukemia & lymphoma ·Christian H. Geisler, Arne Kolstad, Anna Laurell, Riikka Räty, (unknown), (unknown)	3
15	Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single‐nucleotide polymorphism microarray analyses 2009 ·Genes Chromosomes and Cancer ·(unknown), Shinsuke Ninomiya, Riikka Räty, Jaakko Hollmén, Ulla M. Saarinen‐Pihkala, Erkki Elonen, Sakari Knuutila	24
16	Acute lymphoblastic leukemias with normal karyotypes are not without genomic aberrations 2009 ·Cancer Genetics and Cytogenetics ·(unknown), Riikka Räty, Arja Harila‐Saari, Pirjo Koistinen, Eeva‐Riitta Savolainen, Kim Vettenranta, Sakari Knuutila, Erkki Elonen, Ulla M. Saarinen‐Pihkala	11
17	Acute lymphoblastic leukemia in adolescents and young adults in Finland 2008 ·Haematologica ·(unknown), Riikka Räty, Sakari Knuutila, Kim Vettenranta, Arja Harila‐Saari, Esa Jantunen, (unknown), P. Koistinen, Katriina Parto, Pekka Riikonen, (unknown), Raija Silvennoinen, Erkki Elonen, U M Saarinen-Pihkala	75
18	CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults—An array CGH study 2008 ·Leukemia Research ·(unknown), Suvi Savola, Riikka Räty, Kim Vettenranta, Arja Harila‐Saari, Pirjo Koistinen, Eeva‐Riitta Savolainen, Erkki Elonen, Ulla M. Saarinen‐Pihkala, Sakari Knuutila	56
19	Outcome of progressive disease after autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a nation‐wide survey 2005 ·European Journal Of Haematology ·Taru Kuittinen, Tom Wiklund, Kari Remes, Erkki Elonen, T. Lehtinen, Outi Kuittinen, Sirpa Leppä, Matti Putkonen, Riikka Räty, Taina Turpeenniemi‐Hujanen, T. Nousiainen, Esa Jantunen	8
20	Ki‐67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma 2002 ·European Journal Of Haematology ·Riikka Räty, Kaarle Franssila, Heikki Joensuu, Lasse Teerenhovi, Erkki Elonen	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact